Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure

Investigators, 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II); a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N. Engl. J. Med., 334, 1349, 10.1056/NEJM199605233342101 The MERIT-HF Study Group, 1999, Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 Packer, 2001, Effect of carvedilol on survival in severe chronic heart failure, N. Engl. J. Med., 344, 1651, 10.1056/NEJM200105313442201 The Joint Study Group in 2009 of the Japanese Circulation Society Schnabel, 2000, Binding properties of beta-blockers at recombinant beta1, beta2 and beta3-adrenoreceptors, J. Cardiovasc. Pharmacol., 36, 466, 10.1097/00005344-200010000-00008 WRITING COMMITTEE MEMBERS, 2013, 2013 ACCF/AHA guideline for the management of heart failure -a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, Circulation, 128, e240 ESC Committee for Practice Guidelines, 2012, Eur. J. Heart Fail., 14, 803, 10.1093/eurjhf/hfs105 Sato, 2012, Cardiac troponin and heart failure in the era of high-sensitivity assays, J. Cardiol., 60, 160, 10.1016/j.jjcc.2012.06.007 Nakamura, 2014, High-sensitivity cardiac troponin T predicts non-cardiac mortality in heart failure, Circ. J., 78, 890, 10.1253/circj.CJ-13-1372 Latini, 2007, For the Val-HeFT investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure, Circulation, 116, 1242, 10.1161/CIRCULATIONAHA.106.655076 Hori, 2014, Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of Bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study, Heart Vessel., 29, 238, 10.1007/s00380-013-0340-3 Düngen, 2011, CIBIS-ELD investigators and project multicentre trials in the competence network heart failure, titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial, Eur. J. Heart Fail., 13, 670, 10.1093/eurjhf/hfr020 Node, 2009, Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment, Cardiovasc. Diabetol., 8, 5, 10.1186/1475-2840-8-5 Alpert, 2000, J. Am. Coll. Cardiol., 36, 959, 10.1016/S0735-1097(00)00804-4 Gore, 2014, Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay, J. Am. Coll. Cardiol., 63, 1441, 10.1016/j.jacc.2013.12.032 Saunders, 2011, Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study, Circulation, 123, 1367, 10.1161/CIRCULATIONAHA.110.005264 Jespersen, 2008, Myocardial stress in patients with acute cerebrovascular events, Cardiology, 110, 123, 10.1159/000110491 Eichhorn, 1996, Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure, Circulation, 94, 2285, 10.1161/01.CIR.94.9.2285 Takashio, 2013, Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure, J. Am. Coll. Cardiol., 62, 632, 10.1016/j.jacc.2013.03.065 Barbato, 2014, Impact of alpha- and beta-adrenergic receptor blockers on fractional flow reserve and index of microvascular resistance, J. Cardiovasc. Transl. Res., 7, 803, 10.1007/s12265-014-9599-8 Agostoni, 2000, Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure, Am. Heart J., 140, 10.1067/mhj.2000.110282 Olson, 2007, Pulmonary function changes associated with cardiomegaly in chronic heart failure, J. Card. Fail., 13, 100, 10.1016/j.cardfail.2006.10.018 Güder, 2014, Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment, Eur. J. Heart Fail., 16, 1273, 10.1002/ejhf.183 Anderson, 2015, Sympathetic nervous system activation and β-adrenoreceptor blockade in right heart failure, Eur. J. Heart Fail., 17, 358, 10.1002/ejhf.253 Jabbour, 2010, Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial, J. Am. Coll. Cardiol., 55, 1780, 10.1016/j.jacc.2010.01.024 Le Jemtel, 2007, Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure, J. Am. Coll. Cardiol., 49, 171, 10.1016/j.jacc.2006.08.046 Bølling, 2014, Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study, Eur. J. Heart Fail., 16, 678, 10.1002/ejhf.81 Chakraborty, 2014, Convergence in findings from randomized trials and elaborately analysed observational data on mortality reduction with carvedilol in heart failure in comparison with metoprolol, Eur. J. Heart Fail., 16, 595, 10.1002/ejhf.108 Hori, 2004, On behalf of the MUCHA investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial, Am. Heart J., 147, 324, 10.1016/j.ahj.2003.07.023 Xie, 2001, Molecular basis of ethnic differences in drug disposition and response, Annu. Rev. Pharmacol. Toxicol., 41, 815, 10.1146/annurev.pharmtox.41.1.815